Frank Milton Schabel

Frank Milton Schabel's AcademicInfluence.com Rankings

Philosophy

#5646

World Rank

#8511

Historical Rank

Logic

#2886

World Rank

#3957

Historical Rank

philosophy Degrees

Frank Milton Schabel

Biology

#7600

World Rank

#10549

Historical Rank

Biochemistry

#1050

World Rank

#1164

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Frank Milton Schabel's Degrees

PhD Biochemistry University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Frank Milton Schabel Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Frank Milton Schabel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. (1964) (835)
Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. (1975) (602)
Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia. (1963) (403)
cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. (1979) (347)
Concepts for systemic treatment of micrometastases (1975) (343)
Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. (1984) (341)
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. (1970) (320)
Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. (1967) (298)
Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas (1977) (204)
The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A) (1968) (185)
1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. (1972) (163)
The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors. (1969) (161)
Patterns of resistance and therapeutic synergism among alkylating agents. (1978) (144)
Quantitative evaluation of anticancer agent activity in experimental animals (1977) (135)
Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase. (1980) (128)
Antiviral Effect of Guanidine (1961) (120)
Establishment of cross-resistance profiles for new agents. (1983) (111)
Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. (1978) (108)
Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenine (1977) (106)
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology (1984) (91)
Rationale for adjuvant chemotherapy (1977) (89)
Experimental evaluation of potential anticancer agents. VI. Anatomical distribution of leukemic cells and failure of chemotherapy. (1961) (87)
Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms. (1959) (85)
Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole. (1970) (84)
THE MECHANISM OF ACTION OF 3‐DEAZAURIDINE IN TUMOR CELLS SENSITIVE AND RESISTANT TO ARABINOSYLCYTOSINE * (1975) (82)
In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. (1968) (81)
EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA. (1965) (78)
Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. (1975) (75)
Toxicity and anticancer activity of a new triazine antifolate (NSC 127755). (1982) (73)
Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells. (1978) (71)
Surgical adjuvant chemotherapy of metastatic murine tumors (1977) (68)
Structure-activity relationships observed on screening a series of pyrazolopyrimidines against experimental neoplasms. (1957) (63)
Nitrosoureas: a review of experimental antitumor activity. (1976) (60)
Concepts for controlling drug-resistant tumor cells. (1980) (58)
Induced mammary carcinoma in the female rat as a drug evaluation system. (1966) (58)
Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. (1965) (56)
Experimental evaluation of potential anticancer agents. IX. The ribonucleosides and ribonucleotides of two purine antagonists. (1962) (56)
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology. (1984) (54)
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. (1974) (53)
Success and failure in the treatment of solid tumors. II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755. (1969) (53)
Studies on the mode of action of azaserine. (1956) (51)
Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo. (1965) (51)
On the curability of experimental neoplasms. I. Amethopterin and mouse leukemias. (1957) (49)
Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. (1982) (46)
Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy. (1972) (45)
Experimental evaluation of potential anticancer agents. XVI. Basic study of effects of certain anticancer agents on kinetic behavior of model bacterial cell populations. (1965) (45)
On the carcinogenicity of a single intragastric dose of hydrocarbons, nitrosamines, aromatic amines, dyes, coumarins, and miscellaneous chemicals in female Sprague-Dawley rats. (1966) (44)
Antiviral agents as adjuncts in cancer chemotherapy. (1980) (43)
Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster. (1968) (43)
Toxicity Studies in Mice Treated with 1-β-d-Arabinofuranosyl-cytosine (ara-C) (1969) (39)
Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. (1969) (37)
Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971. (1972) (35)
Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters. (1968) (35)
A comparative study of the anticancer activity of some S-substituted derivatives of 6-mercaptopurine and their ribonucleosides. (1961) (34)
Spontaneous AK leukemia (lymphoma) as a model system. (1969) (33)
Antiviral activity of carbobenzosy di- and tripeptides on measles virus. (1968) (32)
Concepts for treatment of micrometastases developed in murine systems. (1976) (31)
Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites. (1965) (28)
Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors. (1979) (28)
Raised somatomedin associated with normal growth hormone. A cause of Beckwith-Wiedemann syndrome? (1980) (28)
Altered sensitivity of a hamster plasmacytoma to cytosine arabinoside (NSC-63878). (1970) (28)
Experimental Evaluation of Potential Anticancer Agents: XII. Quantitative Drug Response of the SA180, CA755, and Leukemia L1210 Systems to a “Standard List” of “Active” and “Inactive” Agents (1963) (27)
Experimental evaluation of potential anticancer agents. I. Quantitative therapeutic evaluation of certain purine analogs. (1961) (26)
Design and evaluation of combination chemotherapy trials in experimental animal tumor systems. (1979) (24)
Some variables in experimental tumor systems which complicate interpretation of data from in vivo kinetic and pharmacologic studies with anticancer drugs. (1978) (23)
Experimental evaluation of potential anticancer agents. XX. Development of immunity to leukemia L1210 in BDF mice and effects of therapy. (1966) (23)
Studies on the mechanism of action and anticancer activity of N-methylformamide. (1955) (22)
Drug control of Ara-C-resistant tumor cells. (1982) (22)
Test Systems for Evaluating the Antitumor Activity of Nucleoside Analogues (1979) (22)
Observations on Antiviral Activity of Netropsin.∗ (1953) (21)
Screening for and biological characterization of antitumor agents using microorganisms. (1961) (21)
Proliferative capacity of leukemic cells in AKR leukemia. (1970) (20)
Inhibition of gross leukemia virus-induced plaque formation in XC cells by 3-deazauridine. (1974) (20)
Therapeutic activity of mitoxantrone and ametantrone against murine tumors. (1983) (19)
The "sensitivity" of resting and dividing cells. (1970) (18)
A quick reference chart on cross resistance between anticancer patients. (1972) (18)
NEW EXPERIMENTAL DRUG COMBINATIONS WITH POTENTIAL CLINICAL UTILITY (1975) (16)
Combination chemotherapy for spontaneous AKR lymphoma. (1974) (16)
In vitro effect of a variety of biologically active compounds on human cytomegalovirus. (1972) (15)
Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure. (1981) (15)
Experimental evaluation of potential anticancer agents. IV. Host weight loss as it relates to false positives in drug evaluation. (1961) (15)
Experimental evaluation of potential anticancer agents. VII. Cross resistance of alkylating agent-resistant neoplasms. (1962) (15)
Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774). (1967) (15)
Response of five established solid transplantable mouse tumors and one mouse leukemia to hyperbaric hydrogen. (1978) (14)
Growth requirements and biologic characteristics of leukemia L1210 cells in culture. (1966) (14)
Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy. (1966) (14)
The inhibition of growth of sarcoma 180 by combinations of B6-antagonists and acid hydrazides. (1956) (14)
Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine. (1977) (13)
Chapter 2 – COMBINATION CHEMOTHERAPY WITH NITROSOUREAS PLUS OTHER ANTICANCER DRUGS AGAINST ANIMAL TUMORS1 (1981) (13)
IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA. (1965) (12)
Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors. (1978) (12)
Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells. (1967) (12)
Clinical concepts derived from animal chemotherapy studies. (1981) (11)
Growth support of small B16 melanoma implants with nitrosourea-sterilized fractions of the same tumor. (1976) (11)
Rationale for perioperative anticancer treatment. (1985) (11)
Experimental evaluation of potential anticancer agents. II. Studies on the growth characteristics, metastases, and drug response of hamster neoplasms of diverse "sites of origin". (1961) (11)
Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice (1980) (10)
The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A). (1968) (10)
Recovery of poliomyelitis virus from the throat during the incubation period. (1947) (10)
Laboratory study of the epidemiology of poliomyelitis. (1948) (9)
Reversal of the growth inhibitory action of urethan by 2, 6-diaminopurine. (1952) (9)
Stool virus recovery in subclinical poliomyelitis during incubation, febrile, and convalescent periods. (1950) (9)
Experimental evaluation of potential anticancer agents. V. In vitro cell culture as a tool in primary drug evaluation and antibiotic isolation. (1961) (9)
Effects of a series of purine analogs on Friend leukemia virus infections in mice. (1968) (9)
Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide. (1978) (8)
Cell kinetics and the chemotherapy of murine solid tumors. (1980) (8)
PURINE AND PYRIMIDINE NUCLEOSIDES AS ANTIVIRAL AGENTS—RECENT DEVELOPMENTS (1970) (8)
[Clinical and immunological aspects of the Schoenlein-Henoch syndrome]. (1974) (8)
Experimental evaluation of potential anticancer agents. X. A specificity test for distinguishing false positives. (1963) (8)
Toxicity studies in mice treated with 1-beta-D-arabinofuranosylcytosine (ara-C). (1969) (7)
Tumor stem cell heterogeneity: implications with respect to classification of cancers by chemotherapeutic effect. (1984) (7)
Absence of delayed lethality in mice treated with aclacinomycin A (2004) (7)
Hereditary deficiency of adenine phosphoribosyl transferase. (1980) (7)
EXPERIENCES IN DEVELOPING POTENTIAL ANTIVIRAL COMPOUNDS (1965) (7)
Structure-activity relationships and cross-resistance observed on evaluation of a series of purine analogs against experimental neoplasms. (1959) (7)
Specific dna inhibitors vs leukemia l1210. Development of resistance to ara-c and ribonucleotide reductase inhibitors. Abstr. (1971) (6)
Incidence of subclinical poliomyelitis in an urban area according to age groups. (1950) (6)
Control of an acute Klebsiella pneumoniae infection in a rhesus monkey colony. (1968) (6)
Inhibition of gross murine leukemia virus replication by rifamycin SV and certain of its derivatives in vitro. (1974) (6)
UTILITY OF DRUG‐RESISTANT ORGANISMS IN CANCER CHEMOTHERAPY STUDIES (1958) (6)
CISDIAMMINE DICHLOROPLATINUM II AOMBINATION CHEMOTHERAPY AND CROSS-RESISTANCE STUDIES WITH TUMORS OF MICE (1979) (6)
Characterization of the biochemical basis of a complete deficiency of the adenine phosphoribosyl transferase (APRT) (2004) (5)
Toxicity of several cancerigenic polycyclic hydrocarbons and other agents in AKR and C57BL-6 mice. (1967) (5)
Potentiated Inhibition of Escherichia coli by Certain Combinations of Agents (1956) (5)
Raised somatomedin associated with normal growth hormone (5)
Susceptibility of the Hamster to St. Louis and Japanese Encephalitis Viruses by Feeding.∗ (1947) (4)
Curative chemotherapy of advanced 239pu-induced osteosarcoma (239pu os) in mice with 2-beta-d-ribofuranosylthiazole-4- -carboxamide (t-car) and of advanced leukemia l1210 with t-car plus bcnu. Abstr. (1983) (4)
Complete Adenine Phosphoribosyltransferase Deficiency with 2,8-Dihydroxyadenine Stone Formation (1981) (4)
Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. (1976) (4)
[Studies on the occurrence of optic nerve diseases in the course of myambutol therapy]. (1972) (4)
Isolation of Poliomyelitis Virus from Human Stools During the Incubation Period.∗ (1948) (4)
Effects of a series of tumor-inhibiting agents and related compounds against a spectrum of mouse-adapted viruses. (1955) (3)
Development of Friend leukemia virus in spleen and plasma of Swiss mice. (1965) (3)
Experimental evaluation of potential anticancer agents. XI. Quantitative response of the Sa180 system to deoxypyridoxine. (1963) (3)
In Vivo Antiviral Properties of Biologically Active Compounds (1968) (3)
Synergistic antileukemic activity of combinations of two nitrosoureas. (1981) (3)
Combination chemotherapy with cyclophosphamide plus melphalan against leukemia l1210. Abstr. (1975) (3)
Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056). (1975) (3)
The use of sulfadiazine and penicillin for treatment of experimental anthrax. (1946) (2)
Shoes as a Potential Hazard to Surgical and Obstetrical Patients (1959) (2)
Combination chemotherapy of ara-c-resistant leukemia p388 (p388/ara-c) with inhibitors of purine and pyrimidine biosynthesis. Abstr. (1983) (2)
Studies on the antimicrobial nature of action of actinobolin. (1961) (2)
Antiviral chemotherapy as an indicated adjunct to cancer chemotherapy. (1975) (2)
Experimental evaluation of potential anticancer agents. III. Reproducibility of primary animal tumor systems employed in the C.C.N.S.C. program. (1961) (2)
Therapeutic potentiation of antileukemic drugs. Abstr. (1968) (2)
Observations on the susceptibility of sooty mangabeys (Cerococebus fuliginosus) and a baboon (Papio papio) to poliomyelitis. (1947) (2)
VIRUS CHEMOTHERAPY - WHY AND HOW. (1965) (2)
Historical development and future promise of the nitrosoureas as anticancer agents. (1973) (1)
Metabolism and chemotherapeutic effects of 9-beta-d-arabino- furanosyl-2-fluoroadenine (f-araa) and evidence for its acti- vation by deoxycytidine kinase. Abstr. (1979) (1)
Therapeutic synergism (ts) of ara-c plus methotrexate (mtx) against murine leukemia l1210. Abstr. (1981) (1)
[Hydrothorax during the neonatal period (author's transl)]. (1979) (1)
[Tetracyclin intoxication versus idiopathic pancreatitis: report of a case with multiple organ involvement (author's transl)]. (1979) (1)
[Anaphylactoid purpura in infancy and childhood (author's transl)]. (1978) (1)
[Glomerulonephritis following snake bite]. (1980) (1)
Antibiotics as antitumor and antiviral substances; panel discussion. (1957) (1)
Screening, the cornerstone of chemotherapy. (1972) (1)
St. Louis and Japanese encephalitis in hamsters following natural feeding of the viruses. (1951) (1)
[Apneas and periodic breathing in mature newborn infants]. (1987) (1)
The "sensitivity" of resting and dividing cells. (1970) (1)
Managers' career expectations are an individual matter (2012) (1)
[Ocular findings in gout and hyperuricemia]. (1971) (1)
[Medullary sponge kidney: a short review and a report of two cases (author's transl)]. (1976) (1)
Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas. (1972) (1)
[Polycythemia in the newborn infant (author's transl)]. (1977) (0)
Combination with cis-dichlorodiammineplatinum ii (cis)-ddpt or mitomycin c (mit c) against leukemia p388 (p388) in mice. Abstr. (1982) (0)
[Infantile transitory distal renal tubular acidosis with bicarbonate loss]. (1985) (0)
Host defense and maximal XYZ effect through small living isografts. (1959) (0)
Inhibition of Ribonucleotide ReducÃ-ase , DNA Synthesis , and L 1210 Leukemia by Guana / (2006) (0)
5-fluorouracil (fu) Against leukemia p388 (p388/0) and ara-c- -resistant p388 (p388/ara-c). Abstr. (1982) (0)
[Investigations on the pathogenesis of distal renal tubular acidosis (author's transl)]. (1979) (0)
[Tubular secretion of phosphate in the human kidney (author's transl)]. (1978) (0)
[Tubular and intestinal phosphate transport in vitamin D-resistant (hypophosphatemic) rickets (author's transl)]. (1977) (0)
DISCUSSION (1965) (0)
[Pharmacokinetic of antibiotics in patients with mucoviscidosis (author's transl)]. (1981) (0)
[Renal glycosuria with loss of phosphate (author's transl)]. (1978) (0)
Concepts for the treatment of tumor metastasis. (1983) (0)
Some observations on the carcinostatic activity of Eponate on Fortner hamster plasmacytoma. (1963) (0)
Laboratory studies on the epidemiology of poliomyelitis. (1947) (0)
Arabinosyl Nucleosides and Nucleotides (2018) (0)
[Pneumoperitoneum in a newborn without intestinal perforation (author's transl)]. (1979) (0)
[Renal upper pole calyceal obstruction: clinical and radiological significance (author's transl)]. (1979) (0)
Recovery of poliomyelitis virus from the throat during the incubation period. (1947) (0)
William S. Wilcox 1922–1968 (1968) (0)
Application of cancer chemotherapy: Introduction. (1978) (0)
[Thrombosis of the renal artery in a newborn (author's transl)]. (1978) (0)
Fundamentals in cancer chemotherapy: introduction. (1978) (0)
Chemotherapy of experimental meningeal leukemia. Abstr. (1963) (0)
Discourse on Kattenbach et al: Same Same but Different – Changing Career Expectations in Germany? (2012) (0)
[Burkitt's lymphoma (author's transl)]. (1976) (0)
[Exaggerated somatomedin activity in the Beckwith-Wiedemann syndrome (author's transl)]. (1979) (0)
Susceptibility of Macacus cynomolgus to Japanese encephalitis virus with special reference to the alimentary tract. (1948) (0)
The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection. (1969) (0)
[Acid-base balance during exchange transfusion (author's transl)]. (1977) (0)
ABSTRACT OF DISCUSSION (2017) (0)
[Recurrent hemolytic-uremic syndrome with positive immunofluorescence]. (1985) (0)
Isolation of the virus of poliomyelitis from the stools, oropharynx and nose of contacts. (1950) (0)
Experimental evaluation of purine antagonists as anticancer agents. (1962) (0)
[Aarskog syndrome (author's transl)]. (1981) (0)
Fundamentals in cancer chemotherapy : anticancer symposia held in connection with the 10th International Congress of Chemotherapy, Zürich, September 18-23, 1977 (1978) (0)
Departments in Transition: How Businesses Organise Their Knowledge Work (2012) (0)
CAMPTOTHECIN OR A CAMPTOTHECIN DERVATIVE AND AN ALKYLATING AGENT FOR THE TREATMENT OF CANCER (2017) (0)
Laboratory studies on the epidemiology of poliomyelitis. (1947) (0)
Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia. (1978) (0)
[Study on seating furniture in pediatric institutions and a proposal for a new children's chair]. (1975) (0)
EPIDEMIOLOGIC IMPLICATIONS OF POLIOMYELITIS VIRUS IN THE THROAT (1949) (0)
Index rerum vol. 13 (1968) (0)
[Polycystic disease of early infancy in two sisters (author's transl)]. (1979) (0)
Title Page / Contents / Antibiotics and Chemotherapy, Vol. 23 Fundamentals in Cancer Chemotherapy (1978) (0)
[Artificial ventilation of preterm and term infants (author's transl)]. (1978) (0)
Recent Results in Cancer Research, Vol. 9. Immunological Aspects of Viral Oncolysis: Jean Lindenmann and Paul A. Klein. P. Rentchnick (ed.). New York: Springer-Verlag, Inc., 1967, 84 pp. $4.50 (1967) (0)
[Experiences with the preventive use of aminophylline (Euphylline) in apnea and periodic respiration in infants]. (1988) (0)
Effects of a Series of Furine Analogs on Friend Leukemia Virus Infections in Mice 1 (2006) (0)
(p388/ara-c) To inhibitors of purine biosynthesis (ipub) and/or pyrimidine biosynthesis (ipyb). Abstr. (1983) (0)
Contents, Vol. 13, 1968 (1968) (0)
Mercury Intoxications During Application of Pharmaceutical Preparations (1980) (0)
Index autorum vol. 13 (1968) (0)
Adenosine deaminase inhibitor. Abstr. (1976) (0)
A Simple Technic for Passage of Certain Viruses. (1947) (0)
Some recent studies on viral encephalitides. (1951) (0)
Complete regression of in vivo osteogenic sarcomas in mice with new azetomicins. Abstr. (1976) (0)
-amino- 2-methyl-5-pyrimidinyl)methyl]-1-2:5,6-dianhydrogalactitol (dag) Against intracerebrally (ic) implanted leukemia l1210. Abstr. (1980) (0)
GrowthSupportof Small B16 Melanoma Implantswith Nitrosourea-sterilizedFractionsof the Same Tumor1 (1976) (0)
In Vivo Antiviral Activity of 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (1965) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Frank Milton Schabel?

Frank Milton Schabel is affiliated with the following schools:

University of Chicago

Frank Milton Schabel's Academic­Influence.com Rankings

Frank Milton Schabel's Degrees

Why Is Frank Milton Schabel Influential?

Frank Milton Schabel's Published Works

Published Works

What Schools Are Affiliated With Frank Milton Schabel?

Frank Milton Schabel's AcademicInfluence.com Rankings